People: Biolase Technology, Inc. (BLTI.O)

BLTI.O on Consolidated Issue listed on NASDAQ Capital Market

1.79USD
10:09am EST
Price Change (% chg)

$0.01 (+0.56%)
Prev Close
$1.78
Open
$1.81
Day's High
$1.81
Day's Low
$1.79
Volume
3,198
Avg. Vol
16,468
52-wk High
$2.88
52-wk Low
$0.30

view people for:

Summary

Name Age Since Current Position
D'Arbeloff, George 64 2006 Chairman of the Board
Pignatelli, Federico 56 2008 Chairman Emeritus, President
Mulder, David 47 2009 Chief Executive Officer, Secretary, Director
Scott, Brett 58 2009 Chief Financial Officer
Anderton, Robert 72 2004 Director
Durrie, Daniel 59 2006 Director
Laird, Neil 56 2006 Director
Largent, James 59 2007 Director
Waller, Gregory 59 2009 Director
» Insider Trading

Biographies

Name Description
D'Arbeloff, George George V. D'Arbeloff is Chairman of Biolase Technology, Inc. George V. D'Arbeloff has served as a Director of Biolase Technology, Inc. since 1996, as lead independent director from March 2006 through May 2006, and as Chairman of Board since May 2006. Since February 2008 Mr. d’Arbeloff has served as a Managing Member of Disruptive Capital Partners, LLC, the managing entity of DCP Premiere Fund, a hedge fund investing in long/short positions in U.S.-based equities. Since 2003, Mr. d’Arbeloff has served as Managing Member of Opus Venture Group, LLC, a company dedicated to providing innovative products for various retail outlet channels. Since 2000, Mr. d’Arbeloff has served and continues to serve as Chairman of the Board of Big Idea Group, Inc., a company that links inventors with companies outsourcing innovation. From 1996 to 2000, Mr. d’Arbeloff served as Chief Executive Officer of Retail Solutions, Inc., a small early-stage private company. From 1967 to 1996, he served in various executive capacities at Teradyne, Inc., a manufacturer of testing equipment for the semiconductor and electronics industries, including Vice President of Investor Relations from 1995 to 1996, Vice President and General Manager of the Semiconductor Test Group from 1992 to 1995 and Vice President and General Manager of the Industrial/Consumer Division of the Semiconductor Test Group from 1982 to 1992.
Pignatelli, Federico Federico Pignatelli is President, Chairman Emeritus of Biolase Technology, Inc. He has served as Chairman of Board from 1994 until March 2006, at which point he resigned as Chairman of Board and received the title Chairman Emeritus. Mr. Pignatelli has served as President since January 2008. From November 2007 to January 2008, Mr. Pignatelli served as interim Chief Executive Officer. He has served as a director since 1991. He is the Founder, and has served as President of Art & Fashion Group since 1992. Art & Fashion Group is a holding company of an array of businesses providing services to the advertising industry, including the world’s largest complex of digital and film still photography studios for production and post-production. Previously, Mr. Pignatelli was a Managing Director at Gruntal & Company, an investment banking and brokerage firm, and was a Managing Director of Ladenburg, Thalmann & Co., another investment banking and brokerage firm.
Mulder, David David M. Mulder is Chief Executive Officer and Director of Biolase Technology, Inc. He has served as a director and Chief Executive Officer since March 5, 2009. Prior to joining the company as Chief Financial Officer in April 2008, Mr. Mulder was the Chief Financial Officer and Chief Operating Officer of American LaFrance, a private equity turn-around company focused on manufacturing emergency vehicles, from January 2006 until August 2007. In January 2008, American LaFrance sought protection under Chapter 11 of the U.S. Bankruptcy Code, and emerged from bankruptcy four months later with approximately 90% of its creditors supporting its plan of reorganization. From 2002 through 2005, he served as the Executive Vice President, Chief Administrative Officer, and Senior Financial Officer of Salton, Inc., a marketer and distributor of household appliances which at the time was a New York Stock Exchange listed company with global revenues of $1.1 billion. Mr. Mulder spent six years with Fruit of the Loom, in progressive financial and operational roles, culminating as the head of the European business in 2000. Mr. Mulder began his professional career in accounting and consulting with Arthur Anderson, and holds an MBA from Duke University, Fuqua School of Business.
Scott, Brett Mr. Brett L. Scott is Chief Financial Officer of BIOLASE Technology, Inc. Most recently he was CFO at Southern California-based North American Scientific, a medical device company that manufactures, markets and sells products used primarily in the treatment of prostate and breast cancer. The prostate business was sold to BEST Medical in April 2009 and the breast business was sold to Portola Medical Inc in May 2009. Prior to North American Scientific, Scott was CFO for Irvine, CA-based Alsius Corporation from January 2006 to August 2008. At Alsius, Scott managed the initial IPO process and was a key member of the negotiating team during the resulting merger with Ithaka Acquisition Company, a specified purpose acquisition company. From September 2001 to March 2005, Scott was CFO at Irvine-based Irvine Biomedical, which was acquired by St. Jude Medical, Inc. in 2004 and designs, develops, manufactures and markets electrophysiology products for the minimally-invasive diagnosis and treatment of cardiac arrhythmias. From July 2001 to December 2002 he was CFO and a member of the Board of Directors of Irvine, CA-based Pain Concepts Inc. that sold its product line to Stryker Medical Inc. in October 2003. He has also been CFO at Cardiac Science and Neuro Navigational Corporation. Mr. Scott has a bachelor of science degree in business administration from the University of Southern California.
Anderton, Robert Robert M. Anderton, DDS, has served as a director of Biolase Technology, Inc. since May 2004. From 1999 to 2001, Dr. Anderton served as the President of the American Dental Association (ADA) as well as holding many official roles with the ADA, including Trustee, Liaison to the Commissions on Dental Accreditation, Council on Education, Government and Legislative Affairs. Dr. Anderton has practiced general dentistry since 1961 and has held several dental society positions, including past President of the Texas Dental Association and Dallas County Dental Society. At various times, Dr. Anderton has published a number of articles in medical and trade journals, including the Journal of the American Society of Preventive Dentistry and Journal of Modern Dental Practice. Dr. Anderton received his DDS degree from Baylor University - College of Dentistry and his J.D. degree from Southern Methodist University - School of Law.
Durrie, Daniel Daniel S. Durrie, M.D, has served as a Director of Biolase Technology, Inc. since March 2006. Dr. Durrie has practiced ophthalmology in the Kansas City area since 1990, establishing Durrie Vision, PA in October 2002. He served on the Board of Directors of the International Society of Refractive Surgery from 1988 to 1990. He was Secretary of the Board of Directors of the International Society of Refractive Surgery from 1999 to 2001. He was also on the Board of Directors of Ophthalmic Imaging Systems from 1998 to 2000. He is on the Medical Advisory Board of Gift of Life and is the Medical Director for Focus on Independence, both 501(c)(3) organizations. He is currently Clinical Professor of Ophthalmology at the University of Kansas Medical Center, and has in the past been a clinical Assistant Professor of Ophthalmology at the University of Missouri at Kansas City and Adjunct Faculty Member at the Pennsylvania College of Optometry. Dr. Durrie has 30 years experience in refractive and corneal surgery. He serves on the editorial boards of Ocular Surgery News, The Journal of Corneal and Refractive Surgery, Review of Ophthalmology, and Refractive Eyecare for Ophthalmologists. Dr. Durrie received his medical doctorate and completed his residency at the University of Nebraska in Omaha, and completed a fellowship in corneal surgery at the Filkins Eye Clinic in Omaha. Dr. Durrie is a board-certified ophthalmologist.
Laird, Neil Neil J. Laird has served as a director of Biolase Technology, Inc. since March 2006. Since 2004, Mr. Laird has served as Chief Financial Officer of SumTotal Systems, Inc., a global provider of learning, performance and talent management solutions. Mr. Laird served as Senior Vice President and Chief Financial Officer of Docent from August 2002 until March 2004. From April until June 2002, Mr. Laird was Chief Financial Officer of Novasonics, Inc., a privately held medical products company. From 1999 to 2001, Mr. Laird was Senior Vice President and Chief Financial Officer of ADAC Laboratories. From 1998 to 1999, Mr. Laird held various executive positions at Coherent Medical Group, a medical laser company. From 1997 to 1998, Mr. Laird was an independent consultant. From 1980 to 1997, Mr. Laird held various executive and managerial financial positions at Measurex Corporation, including Vice President-Corporate Controller. Mr. Laird holds an M.A. degree in economics from Cambridge University and is a United Kingdom Chartered Accountant.
Largent, James James R. Largent has served as a Director of Biolase Technology, Inc. since June 2007. Mr. Largent has 30 years of management experience in the medical device and pharmaceutical industries, including 28 years with Allergan, Inc. where he held various senior management positions including Vice President, Strategic Planning. From 2002 to the present, Mr. Largent has been a consultant to the medical device industry assisting client companies with strategic planning, marketing, reimbursement and business development. In addition to serving on Board, Mr. Largent also serves on the Board of Tear Science, Inc., a privately held developer of diagnostic and therapeutic devices for the treatment of patients with dry eye disease.
Waller, Gregory Mr. Gregory D. Waller is Director of BIOLASE Technology, Inc. He has more than three decades of Board level and senior executive management experience in the medical device industry, including 25 years with Orange, CA-based Sybron Dental Specialties, Inc, a manufacturer of high technology dental, dental implants, and infection prevention products. Mr. Waller also currently serves as a member of the Board of Directors of other medical companies, including Endologix Incorporated, Clarient Inc, Cardiogenesis Corporation and SenoRx, Inc. Mr. Waller has extensive experience in the medical device field that began at Irvine, CA-based American Hospital Supply Corporation (AHSC). Waller spent more than a decade at AHSC, where he served as Harleco Division Operations Manager, McGaw Laboratories Division Plant Controller, and Ormco Division Vice President and Controller, until the sale of AHSC to Sybron Dental in 1982. From 1980 to 1989, he was Vice President and Controller at Ormco and, from 1989 to 1993, he was Vice President, European Operations at Kerr Corporation, each wholly owned subsidiaries of Sybron Dental. From 1993 to 2005, Waller served as Vice President Finance, Chief Financial Officer, and Treasurer at Sybron Dental, where he managed the financial and information technology integration of Kerr and Ormco into Sybron Dental, developed the strategy for consolidating and integrating some 30 strategic acquisitions, managed the spin off of Sybron from Apogent Technologies, and led Sybron's corporate finance activities, including a secondary public stock offering, a new financing facility, and the refinance of the company's existing debt. Mr. Waller is a graduate of California State University, Fullerton, and holds an Master of Business Administration in Accounting and a Bachelor of Arts degree in Political Science.

Basic Compensation

Name Fiscal Year Total
D'Arbeloff, George --
Pignatelli, Federico 241,188
Mulder, David 227,537
Scott, Brett --
Anderton, Robert --
Durrie, Daniel --
Laird, Neil --
Largent, James --
Waller, Gregory --
As Of 30 Dec 2008

Options Compensation

Name Options Value
D'Arbeloff, George 0 0
Pignatelli, Federico 130,000 84,700
Mulder, David 0 0
Scott, Brett 0 0
Anderton, Robert 0 0
Durrie, Daniel 0 0
Laird, Neil 0 0
Largent, James 0 0
Waller, Gregory 0 0

Insider Trading

Name Shares Traded Price
CAPALLO FRED 8,333 $2.26
DURRIE DANIEL S 3,750 $1.24
DURRIE DANIEL S 5,000 $0.78
DURRIE DANIEL S 2,800 $1.18
DURRIE DANIEL S 460 $1.20
PIGNATELLI FEDERICO 200,000 $1.17
DURRIE DANIEL S 400 $1.00
DURRIE DANIEL S 3,826 $1.00
LAIRD NEIL J 5,871 $1.49
LAIRD NEIL J 200 $1.37
LAIRD NEIL J 400 $1.37
LAIRD NEIL J 1,499 $1.38
LAIRD NEIL J 2,030 $1.39
ST PHILIP JAKE 200 $3.18
ST PHILIP JAKE 600 $3.24
ST PHILIP JAKE 200 $3.21
ST PHILIP JAKE 100 $3.23
ST PHILIP JAKE 600 $3.20
ST PHILIP JAKE 4,300 $3.25
ST PHILIP JAKE 4,000 $3.22
D ARBELOFF GEORGE V 10,000 $3.24
D ARBELOFF GEORGE V 2,780 $3.24
D ARBELOFF GEORGE V 2,900 $3.23
D ARBELOFF GEORGE V 14,320 $3.25
LARGENT JAMES R 4,900 $2.93
» Full list on Insider Trading
view people for: